Otilimab (Anti-CSF2 / GM-CSF)
Otilimab (GSK 3196165) is an humanized monoclonal antibody targeting GM-CSF (granulocyte-macrophage colony-stimulating factor). Otilimab neutralises the biological function of GM-CSF by blocking the interaction of GM-CSF with its cell surface receptor. MW: 145.5 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2533 |
| Sku # | A2533-1mg*25 |
| Pricing | 1mg*25, $5070.00 |